SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

Sep 12, 2014

10 likes | 89 Views

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a.

Share Presentation

Embed Code

Link

figure 1a

yachi

Download Presentation

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

82 views • 1 slides

Supplementary figure 1A

Supplementary Figure 1: Comparison of the results obtained from three widely used databases (namely AmiGO, ArrayExpress and GeneCards ) with that from HypoxiaDB . A specific protein PGK1 is searched in HypoxiaDB and in the other databases. The results were compared.

170 views • 8 slides

Supplementary Figure 1A: non-inflamed tonsil

Supplementary Figure 1A: non-inflamed tonsil. #1. #7. #2. #8. #3. #9. #10. #4. #5. #11. #6. #12. Supplementary Figure 1B: chronic tonsillitis. #1. #7. #2. #8. #3. #9. #10. #4. #5. #11. #6. #12.

100 views • 2 slides

Zone 1a & 1b

Zone 1a & 1b. Boundaries North: Old Chelsea Rd with line to river East: Gatineau River South: Gatineau/Hull city limits East: Gatineau Park Zone 1 divided by Rt 5 into 1a (west side) & 1b (east side). Zones 1a & 1b . 1a. 1b. Immediate Challenges.

153 views • 5 slides

Supplementary Figure 1A

Supplementary Figure 1A. Patients with HCC. Patients with No HCC. Model building n = 255. 14.5 %. Yes. No. HBV. n = 35. n = 220. 10.0 %. 42. %. Male. Female. Group 1. Sex. n = 100. n = 120. 3.0 %. 15.8%. Yes. No. Group 2. Exogenous insulin. n = 13. n = 107.

141 views • 4 slides

Supplementary figure

IgG. Supplementary figure.

59 views • 1 slides

Figure 1a:

Figures from : Thompson, D.W.J., and J.M. Wallace, 2000: Annular modes in the extratropical circulation. Part I: Month-to-month variability. J. Climate , 13, 1000-1016. Figure 1a:.

291 views • 8 slides

Figure 1A.

Figure 2. Figure 1A. anti-Epo ab. Streptavidin-HRPO. Adult bone marrow. Epo-biotin (µg). 36. 18. 9. 4.5. 36. 18. 9. 4.5. CD117-. CD117+.

102 views • 1 slides

Figure 1A

A. ADV. ADV+LAM. 8. 500. 400. 6. 300. HBV DNA (Log IU/mL). ALT (IU/mL). 4. 200. 2. 100. 0. 0. M0. M7. M14. M21. M28. M35. M42. M48. M56. Months of therapy. Figure 1A. Figure 1B. B. ADV. ADV+LAM. 10. 1000. 8. 800. 600. 6. HBV DNA (Log IU/mL). ALT (IU/mL). 4.

146 views • 7 slides

Figure 1a

Incidence of experimental BA. *. Incidence in [%]. *p<0.05. Figure 1a. Balb/c Black/6 died died. Survival [%]. days after RRV infection . Figure 1b. CD3 lymphocytes. *. *. *. 30. 20. T cells/0.25 mm 2. 10. 0. +BA - BA cont +BA - BA cont.

144 views • 5 slides

Supplementary Figure

95 views • 1 slides

1A+1B=1C

D. L3. 1A+1B=1C. 55%. A. X. Fila A. X. &. L1. C. X. L2. Op 2. Op 3. Op 2. Op 3. B. Fila B. Op 1. 45%. E. L4. X. X. Op 2. Op 3. Op 2. Op 3.

72 views • 1 slides

Supplementary Figure

Supplementary Figure. PVY CP. PLRV CP. PVA CI. Fig. S1. PVY CP-F. (a). PVY CP -R. PLRV CP-F. PLRV CP-R. attB2. PVA CI-F. (b). PLRV CP. PVY CP. PVA CI. PVA CI-R. attB1. 600bp. P35S. 600bp. Intron. T35S. Kan. (c). LB. RB. pK7GWIWG2(I). Intron R. Intron F. P35SR. T35SF.

168 views • 7 slides

Figure 1a

Figure 1a.

71 views • 1 slides

Supplementary Figure

Supplementary Figure. Body weight gain (g). Days. Supplementary Figure. Body weight gain in control and diabetic rats. Rats were fed a chow or high-fat diet for 21 days, with STZ injected at varying doses at day 14. n = 4 - 11 per group.

89 views • 1 slides

Supplementary Figure 1A

Supplementary Figure 1A. Supplementary Figure 1B. PCLB1. HNF4A. WNT5A. VANGL1.

254 views • 11 slides

Supplementary Figure 1A (male)

Etiocholanolone -S. DHEA-S. P<0.01. P<0.01. 16-OH-DHEA-S. 16/D. P<0.01. P<0.01. 16/E. F0-2 F3-4. P<0.01. Supplementary Figure 1A (male). F0-2 F3-4. DHEA-S. Etiocholanolone -S. N.S. P<0.05. 16-OH-DHEA-S. 16/D. N.S. P<0.01. 16/E. P<0.01.

135 views • 2 slides

Supplementary Figure

Supplementary Figure. Supplementary Figure

81 views • 1 slides

Figure 1a

Figure 1a. Figure 1b.

82 views • 2 slides

Supplementary Figure 1A

Supplementary Figure 1A. p =0.001, log-rank test.

72 views • 1 slides

Supplementary Figure 1A

Supplementary Figure 1A. Supplementary Figure 1B. PCLB1. HNF4A. WNT5A. VANGL1.

117 views • 11 slides

More Related

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

Presentation Transcript

SUPPLEMENTARY TABLE 1b TISSUE CODES FOR FIGURE 1a

Supplementary figure 1A

Supplementary Figure 1A: non-inflamed tonsil

Zone 1a &amp; 1b

Supplementary Figure 1A

Supplementary figure

Figure 1a:

Figure 1A.

Figure 1A

Figure 1a

Supplementary Figure

1A+1B=1C

Supplementary Figure

Figure 1a

Supplementary Figure

Supplementary Figure 1A

Supplementary Figure 1A (male)

Supplementary Figure

Figure 1a

Supplementary Figure 1A

Supplementary Figure 1A

Zone 1a & 1b